CD19 CAR T cell product and disease attributes predict leukemia remission durabilityOlivia Finney, Michael C. Jensen, Roxana Hicks et al.|Journal of Clinical Investigation|2019Cited by 355
Glial injury in neurotoxicity after pediatric CD19‐directed chimeric antigen receptor T cell therapyJuliane Gust, Rebecca Gardner, Olivia Finney et al.|Annals of Neurology|2019Cited by 191